Lash et al.
615.1866, found 615.1863. Anal. Calcd for C36H35N3Pd‚2/5CHCl3:
C, 65.85; H, 5.37; N, 6.33. Found: C, 65.53; H, 5.34; N, 6.22.
[8,17-Diethyl-7,18-dimethyl-12,13-diphenylazuliporphyrinato]-
palladium(II) (15b). A mixture of diphenylazuliporphyrin 8b (25
mg) and palladium(II) acetate (15 mg) in DMF (30 mL) was heated
for 10 min at 80-90 °C. The mixture was diluted with chloroform
and washed with water. The organic solvent was removed in Vacuo,
and the residue was chromatographed on silica gel eluting with
chloroform. Recrystallization from chloroform-hexanes gave the
palladium(II) diphenylazuliporphyrin 15b (21 mg, 72%) as black
crystals, mp >300 °C. UV-vis (5% Et3N-CHCl3): λmax (log ꢀ)
nickel(II) acetate tetrahydrate (10 mg) in DMF (10 mL) under reflux
for 20 min and the solution cooled to room temperature. The
mixture was diluted with chloroform, washed with water, and dried
over sodium sulfate. The solvent was evaporated on a rotary
evaporator; residual DMF was removed using an oil pump. The
residue was chromatographed on a grade III alumina column, eluting
with 20% hexanes-dichloromethane. The product was obtained
as a green fraction. Recrystallization from chloroform-hexanes
gave the nickel(II) complex (8.8 mg; 81%) as lustrous green
crystals, mp >300 °C. UV-vis (CHCl3): λmax (log ꢀ) 400 (4.84),
1
468 (4.65), 488 (4.67), 594 (4.15), 649 (4.18), 794 nm (3.54). H
1
NMR (CDCl3): δ 6.75 (2H, t, J ) 10 Hz), 7.08 (1H, t, J ) 9.4
Hz), 7.37 (2H, d, J ) 10 Hz), 7.56-7.65 (12H, m), 7.82-7.90
(10H, m), 8.00 (2H, s), 8.06 (2H, d, J ) 4.8 Hz). 13C NMR
(CDCl3): δ 117.8, 127.2, 127.3, 127.5, 127.9, 129.0, 129.6, 130.0,
132.5, 133.0, 133.5, 133.6, 135.2, 137.7, 141.2, 141.8, 146.5, 148.2,
151.8, 156.5, 166.0. HRMS (FAB): m/z calcd for C50H31N3Ni +
H 732.1950, found 732.1950. Anal. Calcd for C50H31N3Ni‚
1/2CHCl3: C, 76.57; H, 4.01; N, 5.30. Found: C, 76.64; H, 3.85;
N, 5.39.
380 (4.82), 415 (4.78), 450 (4.69), 580 (4.15), 638 nm (3.92). H
NMR (CDCl3; 50 °C): δ 1.59 (6H, t, J ) 7.6 Hz), 3.14 (6H, s),
3.42 (4H, q, J ) 7.6 Hz), 7.33-7.41 (3H, m), 7.51 (2H, t, J ) 7.4
Hz), 7.58 (4H, t, J ) 7.6 Hz), 7.83 (4H, d, J ) 7.2 Hz), 8.75 (2H,
1
br s), 8.81 (2H, d, J ) 9.2 Hz), 9.10 (2H, br s). H NMR (d5-
pyridine): δ 1.55 (6H, t, J ) 7.4 Hz), 3.16 (6H, s), 3.40 (4H, q, J
) 7.4 Hz), 7.52 (2H, t, J ) 7.6 Hz), 7.57-7.60 (3H, m), 7.63 (4H,
t, J ) 7.6 Hz), 8.01 (4H, d, J ) 7.2 Hz), 9.23 (2H, s), 9.42 (2H,
m), 9.82 (2H, s). 13C NMR (d5-pyridine): δ 11.4, 17.1, 20.0, 100.7,
110.7, 123.4, 126.8, 128.4, 129.4, 132.7, 133.0, 137.7, 137.9, 141.8,
143.3, 149.3, 156.0. HRMS (EI): m/z calcd for C44H35N3Pd
711.1866, found 711.1882. Anal. Calcd for C44H35N3Pd‚1/10-
CHCl3: C, 73.15; H, 4.88; N, 5.80. Found: C, 73.28; H, 4.70; N,
5.72.
[5,10,15,20-Tetrakis(4-chlorophenyl)azuliporphyrinato]nickel-
(II) (17b). Tetrakis(4-chlorophenyl)azuliporphyrin 13b (10.0 mg)
was reacted with nickel(II) acetate tetrahydrate (10 mg) in DMF
(20 mL) under the foregoing conditions. Recrystallization from
chloroform-hexanes gave the organometallic complex (7.0 mg;
65%) as lustrous green crystals, mp 252-256 °C, dec. UV-vis
(CHCl3): λmax (log ꢀ) 400 (4.88), 473 (4.69), 490 (4.70), 591 (4.19),
[8,12,13,17-Tetraethyl-7,18-dimethylazuliporphyrinato]-
platinum(II) (16a). A mixture of azuliporphyrin 8a (26.0 mg) and
platinum(II) chloride (16 mg) in DMF (25 mL) was heated under
reflux for 15 min. The mixture was diluted with chloroform and
washed with water. The organic solvent was removed in vacuo,
and the residue was chromatographed on silica gel eluting with
chloroform. Recrystallization from chloroform-hexanes gave the
title platinum(II) complex (9.5 mg, 27%) as black crystals, mp >300
°C. UV-vis (CHCl3): λmax (log ꢀ) 367 (4.97), 427 (4.55), 442
(4.62), 513 (4.34), 551 (4.31), 621 (4.04), 670 (infl, 3.97), 741 nm
1
647 (4.21), 796 nm (3.60). H NMR (CDCl3): δ 6.91 (2H, t, J )
10.2 Hz), 7.21 (1H, t, J ) 9.6 Hz), 7.43 (2H, d, J ) 10.4 Hz),
7.56-7.61 (8H, m), 7.76-7.81 (10H, m), 7.97 (2H, s), 8.02 (2H,
d, J ) 5.2 Hz). 13C NMR (CDCl3): δ 116.8, 127.6, 127.7, 129.7,
130.0, 132.5, 132.9, 134.0, 134.4, 134.5, 134.7, 135.2, 135.8, 138.1,
139.4, 140.0, 146.5, 148.3, 151.7, 156.5, 165.8. HRMS (FAB): m/z
calcd for C50H27Cl4N3Ni 867.0313, found 867.0314. Anal. Calcd
for C50H27Cl4N3Ni‚1/5CHCl3: C, 67.43; H, 3.06; N, 4.70. Found:
C, 67.60; H, 2.91; N, 4.76.
1
(infl, 3.56). H NMR (CDCl3-d5-pyridine): δ 1.66 (6H, t, J )
Hz), 1.70 (6H, t, J ) Hz), 3.19 (6H, s), 3.47-3.55 (8H, 2
overlapping quartets), 7.31 (2H, t, J ) 9.6 Hz), 7.63 (1H, t, J )
9.6 Hz), 8.86 (2H, singlet with platinum-195 satellites, 4JPt,H ) 4.4
Hz), 9.24 (2H, d, J ) 9.6 Hz), 9.37 (2H, singlet with platinum-195
satellites, 4JPt,H ) 5.3 Hz). HRMS (FAB): m/z calcd for C36H35N3-
Pt 704.2479, found 704.2482.
[5,10,15,20-Tetraphenylazuliporphyrinato]palladium(II) (18a).
Tetraphenylazuliporphyrin 13a (10.0 mg) was heated under reflux
with palladium(II) acetate (5 mg) in DMF (10 mL) for 10 min and
the solution cooled to room temperature. The mixture was diluted
with chloroform, washed with water, and dried over sodium sulfate.
The solvent was evaporated on a rotary evaporator; residual DMF
was removed using an oil pump. The residue was chromatographed
on a grade III alumina column, eluting with 20% hexanes-
dichloromethane. The product was obtained as a green fraction.
Recrystallization from chloroform-hexanes gave the palladium-
(II) complex (7.8 mg; 67%) as a lustrous black powder, mp > 300
°C. UV-vis (CHCl3): λmax (log ꢀ) 375 (4.69), 402 (4.83), 481
(4.75), 586 (4.28), 629 (4.26), 791 nm (3.68). 1H NMR (d5-
pyridine): δ 6.96 (2H, t, J ) 9.8 Hz), 7.25 (1H, t, J ) 10 Hz),
7.61-7.68 (12H, m), 7.71 (2H, d, J ) 10.4 Hz), 7.94-7.97 (4H,
m), 8.06-8.09 (4H, m), 8.23 (2H, d, J ) 5.2 Hz), 8.26 (2H, s),
8.38 (2H, d, J ) 4.8 Hz). 13C NMR (d5-pyridine): δ 119.8, 127.1,
127.3, 127.5, 127.8, 128.2, 129.5, 132.2, 132.5, 132.6, 133.6, 133.9,
136.6, 137.0, 139.3, 142.5, 143.2, 144.9, 147.7, 160.5. HRMS
(FAB): m/z calcd for C50H31N3Pd 779.1553, found 779.1554. Anal.
Calcd for C50H31N3Pd‚1/8CHCl3: C, 75.71; H, 3.94; N, 5.28.
Found: C, 75.38; H, 3.74; N, 5.12.
[8,17-Diethyl-7,18-dimethyl-12,13-diphenylazuliporphyrinato]-
platinum(II) (16b). A mixture of diphenylazuliporphyrin 8b (20.0
mg) and platinum(II) chloride (14 mg) in DMF (25 mL) was reacted
under the foregoing conditions. Recrystallization from chloroform-
hexanes gave the platinum(II) azuliporphyrin 16b (6.1 mg, 23%)
as black crystals, mp > 300 °C. UV-vis (5% Et3N-CHCl3): λmax
(log ꢀ) 372 (5.03), 420 (4.62), 442 (4.68), 521 (4.37), 560 (4.41),
629 (4.145), 670 (4.12), 750 nm (infl, 3.63). 1H NMR (d5-
pyridine): δ 1.63 (6H, t, J ) 7.4 Hz), 3.23 (6H, s), 3.42 (4H, q, J
) 7.4 Hz), 7.35 (2H, t, J ) 9.6 Hz), 7.57 (2H, t, J ) 7.4 Hz),
7.63-7.70 (5H, m), 7.98 (4H, d, J ) 7.2 Hz), 9.09 (2H, singlet
with platinum-195 satellites, 4JPt,H ) 4.4 Hz), 9.24 (2H, d, J ) 10
Hz), 9.43 (2H, singlet with platinum-195 satellites, 4JPt,H ) 5.6 Hz).
13C NMR (CDCl3-d5-pyridine): δ 9.1, 14.5, 17.8, 98.6, 110.3, 126.2,
127.1, 130.4, 136.1, 137.4, 138.2, 138.6, 139.6, 157.6. HRMS
(EI): m/z calcd for C44H35N3Pt 799.2458, found 799.2458. Anal.
Calcd for C44H35N3Pt‚1/3CHCl3: C, 58.63; H, 4.78; N, 5.64.
Found: C, 58.62; H, 4.87; N, 5.50.
[5,10,15,20-Tetrakis(4-chlorophenyl)azuliporphyrinato]-
palladium(II) (18b). Tetrakis(4-chlorophenyl)azuliporphyrin 13b
(10 mg) was reacted with palladium(II) acetate (10.0 mg) in DMF
(20 mL) under the foregoing conditions. Recrystallization from
chloroform-hexanes gave the organometallic derivative (11.0 mg;
Metal Complexes of meso-Tetraaryl Substituted Azulipor-
phyrins. [5,10,15,20-Tetraphenylazuliporphyrinato]nickel(II)
(17a). Tetraphenylazuliporphyrin 13a (10.0 mg) was heated with
7336 Inorganic Chemistry, Vol. 42, No. 22, 2003